COMMAND DASHBOARD
Company snapshot: $86.6M funding, $23M ARR, 112 headcount, no disclosed valuation. Ambient AI scribe competing against Abridge, Nuance DAX Copilot, Suki, and EHR-native offerings in clinical documentation space.
PLG-to-enterprise transition tension: Bottom-up adoption strength requires formal enterprise GTM (security reviews, procurement, IT integration, executive sponsorship) demanding new sales motions, enablement, and partner/channel strategy for US/UK/Canada expansion.
Integration depth vs. incumbents: Stance of not over-optimizing for deep Epic integration reduces near-term lock-in but limits wins in large health systems where workflow depth inside EHR (write-back, structured data, coding/billing) is decisive.
Reliability and scalability strain: Third-party review noted surge in US usage causing server issues/glitches before demos, indicating infrastructure and customer experience strain during hypergrowth phase.
RevOps data fragmentation risk: Hybrid GTM (self-serve clinicians + SMB clinics + emerging enterprise) creates multi-CRM/channel attribution issues, inconsistent lead/contact/account hierarchies, and difficulty forecasting expansion without tight product usage to sales stage connection.

Heidi's revenue infrastructure was built for PLG but lacks the enterprise sales machinery to capture large health system deals. No unified revenue operating model exists across self-serve and sales-led motions, creating attribution chaos and missed expansion opportunities as the company scales internationally.

Days 1–90Q1 — FOUNDATION
Days 91–180Q2 — BUILD
Days 181–270Q3 — SCALE
Days 271–365Q4 — OPTIMIZE
Conservative

$12M new enterprise ARR

Target

$18M new enterprise ARR

Stretch

$25M new enterprise ARR (assumes 3 major health system platform deals above $2M ACV)

Strategic Summary

Core Opportunity

Heidi Health has strong bottom-up adoption but lacks enterprise revenue infrastructure to capture large health system deals requiring formal procurement, deep EHR integration, and structured expansion motions.

Execution Thesis

Deploy unified revenue operating model with PLG-to-enterprise conversion automation, segmented GTM plays, and EHR integration depth to convert clinical adoption into $12M–$25M enterprise ARR while maintaining unit economics through AI cost optimization.

Production systems, not theory. Revenue captured, not demos given.